Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Using financial plans to reach life objectives can streamline your path to success. Discover how to create a plan that works for you.
22,378 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Two cloud software giants sit side by side in the growth-at-any-cost debate. This article breaks down whether should ...
Nike’s quarterly results hide a fragile rebound, with internal missteps and regional weakness clouding CEO Elliott Hi...
Tech shares rallied as semiconductors staged a comeback, lifting the Nasdaq Composite by 0.9%. This article explains ...
Warren Buffett unveils a sweeping update to his charitable giving, moving billions of dollars to four family-led foun...
OpenAI is nearing a private funding round that could push its valuation above $850 billion, a level that would outstr...
Only three U.S. companies hover above $3 trillion in market value today. This article explores a spectacular stock be...
Target has stunned the market with surprising margins and a rebound in sales. This article digs into whether the rall...
Boards are rethinking CEO selection, prioritizing agility and AI fluency over years on the job. The shift could upend...
Archer Aviation is venturing into urban air mobility with electric VTOL aircraft. This piece analyzes the case for bu...
Could a bold thesis around Oklo Inc. unlock life-changing gains? This forward-looking guide breaks down why nuclear e...
Intel Arrow Lake Refresh introduces budget-friendly CPUs with stronger cores, bigger caches, and aggressive pricing. ...